Direct Acting Agents in Hepatitis C Patients

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

NCT03887637 ·Status: UNKNOWN

Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients

NCT03163849 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C

NCT02639585 ·Status: UNKNOWN ·Phase: PHASE4

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

NCT03510637 ·Status: UNKNOWN

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

NCT03423641 ·Status: COMPLETED

Quantification of Side Effects During Hepatitis C Therapy

NCT02545400 ·Status: COMPLETED

Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C

NCT04952207 ·Status: UNKNOWN

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

NCT04662138 ·Status: UNKNOWN

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

NCT03520660 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection

NCT03603327 ·Status: COMPLETED ·Phase: NA

Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

NCT05895448 ·Status: UNKNOWN ·Phase: PHASE4

Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam

NCT03601546 ·Status: UNKNOWN

Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

NCT01459419 ·Status: UNKNOWN ·Phase: PHASE2

Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego

NCT03551002 ·Status: UNKNOWN

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

NCT00671671 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

NCT01842451 ·Status: COMPLETED ·Phase: PHASE2

3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection

NCT01349465 ·Status: COMPLETED ·Phase: PHASE3

Very Rapid and Rapid Virological Response as Predictors of Response of HCV Tretment

NCT03480269 ·Status: UNKNOWN

Pharmacogenomic Research in Korean Patients With Hepatitis C

NCT01453244 ·Status: COMPLETED

Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir

NCT03818308 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

NCT01508130 ·Status: COMPLETED

Hepatitis C Virus Infection in Patients With Hemoglobinopathies

NCT03149289 ·Status: COMPLETED

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

NCT01121705 ·Status: COMPLETED ·Phase: PHASE3

Micro-elimination of Hepatitis C Virus Infection in Uremics

NCT03891550 ·Status: UNKNOWN ·Phase: PHASE3

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

NCT02339207 ·Status: COMPLETED ·Phase: PHASE1